Guardant Health, Inc.
Company Information
Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 3100 HANOVER STREET, PALO ALTO, CA, 94304
Mailing Address 3100 HANOVER STREET, PALO ALTO, CA, 94304
Phone 855-698-8887
Fiscal Year End 1231
EIN 454139254
Financial Overview
FY2024
-$436.37M
Net Income
$1.79B
Total Assets
$1.63B
Total Liabilities
$1.13B
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 2, 2026 | View on SEC |
| 5 Annual insider ownership changes | January 22, 2026 | View on SEC |
| 5 Annual insider ownership changes | January 22, 2026 | View on SEC |
| 4 Insider stock transaction report | January 22, 2026 | View on SEC |
| 5 Annual insider ownership changes | January 22, 2026 | View on SEC |
| 4 Insider stock transaction report | January 22, 2026 | View on SEC |
| 4 Insider stock transaction report | January 20, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
Insider Trading
STRONG SELL 10 insiders
55 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.